Key facts
- It has raised $21.9M.
- Notable investors include US National Science Foundation, Texas Medical Center, Advanced Technology Development Center, Cedars-Sinai Accelerator, Healthcare Innovation Pitch — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for RCE.ai
- ·The full record, as it builds
Funding rounds
No funding rounds for RCE.ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About RCE.ai
Developer of an artificial intelligence-enabled medical device designed for the early detection of heart attacks. The company's device intends to detect severe coronary artery obstruction in symptomatic chest-pain patients using a non-invasive transdermal technique, enabling doctors to give timely diagnostics and the potential to improve patient outcomes.
- Sector
- Healthcare
- HQ
- Carlsbad, CA, United States
- Founded
- 2018
- Employees
- 6
- Website
- rce.ai/
- Ownership
- Privately Held (backing)
RCE.ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RCE.ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RCE.ai in its N-PORT filings yet. We sweep new filings monthly.